Información del artículo
El Texto completo está disponible en PDF
Bibliografía recomendada
[1.]
M. Allen, E.C. Siegried.
The natural history of condyloma in children.
J Am Acad Dermatol, 39 (1998), pp. 951-955
[2.]
F.X. Bosch, X. Castellsagué, N. Muñoz, S. De Sanjosé, A.M. Ghaffari, L.C. González, et al.
Male sexual behavior and Human Papillomavirus DNA: key risk factors for cervical cancer in Spain.
J Natl Cancer Inst, 88 (1996), pp. 1060-1067
[3.]
F.X. Bosch, M. Manos, N. Muñoz, M. Sherman, A. Jansen, J. Peto, and the IBSCC study group, et al.
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.
J Natl Cancer Inst, 87 (1995), pp. 796-802
[4.]
F.X. Bosch, N. Muñoz, X. Castellsagué.
Epidemiology of cervical dysplasia and neoplasia.
Cancer and pre-cancer of the cervix, pp. 51-68
[5.]
F.X. Bosch, T. Rohan, A. Schneider, I. Frazer, H. Pfister, X. Castellsagué, et al.
Papillomavirus research: updating results to the year 2000. Highlights of the HPV 2000 International Papillomavirus Conference.
J Clin Pathol, 4 (2001), pp. 25-34
[6.]
X. Castellsagué, A. Ghaffari, R.W. Daniel, F.X. Bosch, N. Muñoz, K.V. Shah.
Prevalence of penile HPV DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia.
J Infect Dis, (1997), pp. 176
[7.]
Prevention Centers for Disease Control and.
Guidelines for treatment of sexually transmitted diseases.
Mmwr, 47 (1998), pp. 88-98
[8.]
R. Comino.
Infección por papilomavirus en ginecología, Arké 144, (1995),
[9.]
R. Comino.
Neoplasia cervical intraepitelial, Arké 144, (1996),
[10.]
G. De Palo, W. Chanen, S. Dexeus.
Patología y tratamiento del tracto genital inferior, Masson, (2000),
[11.]
S. De Sanjosé, F.X. Bosch, N. Muñoz, S. Chichareon, C. Ngelangel, L. Balagueró, et al.
Screening for genital HPV: results from an international study on HPV sampling techniques.
Diagnostic Molec Pathol, 8 (1999), pp. 26-31
[12.]
S. De Sanjosé, I. Valls, M.P. Cañadas, B. Lloveras, M.J. Quintana, K.V. Shah, et al.
La infección por el virus del papiloma humano (VPH) y el virus de la immunodeficiencia (VIH) como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas.
Med Clin (Barc), 115 (2000), pp. 81-84
[13.]
L. Edwards, A. Ferenczy, L. Eron, D. Baker, M.L. Owens, T.L. Fox, et al.
Self-administered topical 5% Imiquimod cream for external genital warts.
Arch Dermatol, 134 (1998), pp. 25-30
[14.]
B.K. Fisher, L.J. Margesson.
Genital skin disorders.
Diagnosis and treatment, Mosby-Yearbook Inc., (1998),
[15.]
S. Franceschi, N. Muñoz, F.X. Bosch, P.J.F. Snijders, J.M.M. Walboomers.
Human papillomavirus and cancers of the upper aero-digestive tract: a review of epidemiological and experimental evidence.
Cancer Epidemiol Biomark Prev, 5 (1996), pp. 567-575
[16.]
E. Franco, J. Monsonego.
New developments in cervical cancer cribado and prevention, Blackwell Science, (1997),
[17.]
G.E. Gross, R. Barrasso.
Human papiloma virus infection.
A clinical atlas, Ullstein Mosby, (1997),
[18.]
M.R. Hammerschlang.
Sexually transmitted diseases in sexually abused children: medical and legal implications.
Sex Transm Infect, 74 (1998), pp. 167-174
[19.]
A.T. Lorincz, R. Reid.
Virus del papiloma humano. Parte I y II. Clin Gin Obst. Temas actuales. Vols. 3 y 4.
McGraw-Hill Interamericana, (1996),
[20.]
R.D. Maw, M. Reitano, M. Roy.
An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle.
Int J STD & AIDS, 9 (1998), pp. 571-578
[21.]
N. Muñoz, X. Castellsagué, F.X. Bosch, L. Tafur, S. De Sanjosé, N. Aristizabal, et al.
Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease.
J Natl Cancer Inst, 88 (1996), pp. 1068-1075
[22.]
E.R. Myers, D.C. McCrojy, K. Nanda, L. Bastian, D.B. Matchar.
Mathematical model for the natural history of human papilomavirus infection and cervical carcinogenesis.
Am J Epidemiol, 151 (2000), pp. 1158-1171
[23.]
M.A.E. Nobbenhuis, J.M.M. Walboomers, T.J.M. Helmerhorst, L. Rozendaal, A.J. Remmink, E.K.J. Risse, et al.
Relation of human papillomavirus status to cervical lesions and consequences for cervical- cancer screening: a prospective study.
Lancet, 354 (1999), pp. 20-25
[24.]
V. Palacio López.
Infección VPH en el área genital.
Clínica, diagnóstico y tratamiento, 3M, (2000),
[25.]
M.H. Schiffman, K.L. Liaw, R. Herrero, M.E. Sherman, A. Hildesheim.
Epidemiologic support for a simplified view of cervical carcinogenesis.
Gen Infect Neoplas Update, Eurogin Scientific Publications, (1998),
[26.]
A. Singer, J.M. Monaghan.
Lower genital tract precancer.
Colposcopy, pathology and treatment, 2.a ed,
[27.]
P.L. Stern, M.A. Stanley.
Human papilomaviruses and cervical cancer.
Biology and immunology, Oxford University Press, (1994),
[28.]
K. Syrjanen, S. Syrjanen.
Infections in human pathology, John Wiley & Sons, (2000),
[29.]
J.J. Vilata Corell.
Enfermedades de transmisión sexual, Prous, (1993),
[30.]
A.P. Vizcaíno, V. Moreno, F.X. Bosch, N. Muñoz, X.M. Barros-Dios, D.M. Parkin.
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
Int J Cancer, 75 (1998), pp. 536-545
[31.]
A.P. Vízcaino, V. Moreno, F.X. Bosch, N. Muñoz, X.M. Barros-Dios, J. Borrás, et al.
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma.
Int J Cancer, 86 (2000), pp. 429-435
[32.]
G. Von Krogh, C.J.N. Lacey, G.E. Gross, R. Barrasso, A. Schneider.
European course on VPH associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.
Sexually Transmitted Infections, 76 (2000), pp. 162-168
[33.]
J.M.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, et al.
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
J Pathol, 189 (1999), pp. 12-19
[34.]
E.K. Wilkinson, B. Kneale, P.J. Lynch.
Report of the ISSVD. Terminology Committee.
J Reprod Med, 31 (1986), pp. 973-974
Copyright © 2001. Sociedad Española de Ginecología y Obstetricia